ADMT - ADM Tronics Unlimited, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.168
0.000 (0.00%)
As of 12:45PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.168
Open0.000
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.000 - 0.000
52 Week Range
Volume0
Avg. Volume27,060
Market Cap11.355M
Beta-1.72
PE Ratio (TTM)33.60
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • ACCESSWIRE9 days ago

    ADM Tronics Invited to Present Aurex-3(R) Tinnitus Technology at International Tinnitus Conference

    NORTHVALE, NJ / ACCESSWIRE / June 13, 2018 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced that its' subsidiary, Aurex International Corp ("AIC"), has been invited to present at the "26th Annual International Conference on Management of the Tinnitus & Hyperacusis Patient" to be held June 14 and 15, 2018 at the University of Iowa. Among the notable speakers and sessions to be presented at this worldwide conference, Dr. Mark Brenner, CEO of AIC, will be presenting current development efforts on the Aurex-3, non-invasive therapy device for the treatment and control of tinnitus.

  • ACCESSWIRE2 months ago

    ADM Tronics Investor Update

    March 31, 2018 marked the completion of ADMT's fiscal year. It also marked the planned inception of the Company's new business model - to re-position ADMT as a developer of its own "brand name" medical technologies. Management is thankful for the combined efforts of its Medical Device Engineering Services division and Aqua Based Technologies division for generating record revenues and profits over the past three years.

  • ACCESSWIRE2 months ago

    ADM Tronics Featured on OTC Markets Podcast

    NORTHVALE, NJ / ACCESSWIRE / April 26, 2018 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT ) announced today that OTC Markets featured an interview with ADMT President, Andre' DiMino on the OTC Markets website ...

  • ACCESSWIRE2 months ago

    OTC Markets Lists ADM Tronics as Exempt from Penny Stock Designation

    NORTHVALE, NJ / ACCESSWIRE / April 19, 2018 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT ) announced today that OTC Markets has identified ADMT as "Penny Stock Exempt - This security is not a Penny ...

  • ACCESSWIRE3 months ago

    Tinnitus & Hearing Shield(TM) - New Patent-Pending Hearing Protection Technology Launched by ADM Tronics Subsidiary

    NORTHVALE, NJ / ACCESSWIRE / March 19, 2018 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT ) announced today that its subsidiary, Aurex International Corporation ("AIC"), has launched its first product ...

  • ACCESSWIRE4 months ago

    ADM Tronics Reports Third Quarter of Fiscal Year 2018 Results

    NORTHVALE, NJ / ACCESSWIRE / February 14, 2018 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT ), a technology-based developer and manufacturer of innovative technologies and products, today announced results ...

  • PR Newswire5 months ago

    ADM Tronics subsidiary, Aurex International Corporation, prepares to launch new hearing protection product - Tinnitus Shield™

    NORTHVALE, N.J. , Feb. 1, 2018 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies has authorized its subsidiary, Aurex International ...

  • PR Newswire5 months ago

    ADM Tronics Presents Outlook for 2018

    NORTHVALE, N.J., Jan. 17, 2018 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (ADMT), a technology-based developer and manufacturer of innovative technologies and products, today released the following investor update. In 2013 ADMT management remodeled its business plan by implementing a strategy which would focus primarily on maximizing its "concept to quantity" engineering, regulatory and manufacturing division.  The objective was to increase cash flow and reserves to internally fund the development of ADMT's proprietary medical technologies. Although deploying the majority of its financial and human resources to this plan was laden with inherent risk, the strategy proved successful, providing increased profits in 17 of its last 18 quarters, eliminating debt and developing a cash reserve.  This allowed the Company to follow-through on its strategic plan to shift a larger portion of its resources to advancing four of its own medical technology products in preparation for launch over the next year.

  • PR Newswire6 months ago

    ADM Tronics Receives Fast 50 Award at Award Ceremony (Video)

    NORTHVALE, N.J. , Dec. 29, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) received the "Fast 50 Award" from NJBIZ, New Jersey's leading business journal at a recent gala awards ...

  • PR Newswire7 months ago

    ADM Tronics Investor Update - Advanced Technologies on the Horizon

    NORTHVALE, N.J., Nov. 28, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (ADMT), a technology-based developer and manufacturer of innovative technologies and products, today released the following investor update. In 2013 ADMT management remodeled the company's business plan, focusing on its core competency in medical device services for the design, development, regulatory and manufacturing of medical devices for clients. As a result of this strategy, ADMT reported profits in 17 of its last 18 quarters.

  • PR Newswire7 months ago

    ADM Tronics Reports Profit for Second Quarter of Fiscal Year 2018

    NORTHVALE, N.J. , Nov. 20, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results ...

  • PR Newswire8 months ago

    ADM Tronics Selected as a "2017 NJBIZ Fast 50" Award Winner

    NORTHVALE, N.J., Oct. 11, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB - ADMT) has just been selected by NJBIZ, New Jersey's leading business journal, as one of the 2017 Fast 50 Award Winners.  The 50 Fastest Growing Companies awards program honors New Jersey's most dynamic businesses who progressively contribute to the success of the state's economic growth and stability. As previously announced, ADMT is close to the launch of a hearing protection product, Tinnitus Shield™, which will help protect from excessive noise that can lead to tinnitus, a hearing condition where there is constant ringing in the ears.  In addition, ADMT is redesigning its non-invasive tinnitus treatment device, the Aurex-3®, which is intended for use for the treatment and control of tinnitus by those already suffering from this debilitating condition.

  • PR Newswire9 months ago

    ADM Tronics Prepares New Respiratory Therapy Device for Market

    NORTHVALE, N.J., Oct. 3, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB - ADMT) is in the final stage of developing the Alvio™ device, a new technology it has had under development pursuant to its previously announced agreement with QOL Devices, Inc. ("QOL").  Alvio is a respiratory therapy and training platform targeted for use in non-regulated respiratory training applications as well as for medical respiratory indications. "It is exciting to see the Alvio approaching commercialization," stated Bez Arkush, founder and President of QOL.  "We have already had significant interest from many major medical institutions, healthcare professionals and international distributors for the Alvio, so it is great to see it now taking shape.  I am pleased to be working with ADMT which has the development, regulatory expertise and experience to bring this breakthrough technology to market." ADMT is the exclusive manufacturer of Alvio technology.

  • PR Newswire9 months ago

    ADM Tronics Investment Report Issued by OneMed Research

    NORTHVALE, N.J. , Sept. 14, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced that OneMed Research has issued an investment report on ADMT. Andre' DiMino, ADMT President, stated, ...

  • PR Newswire10 months ago

    ADM Tronics Reports First Quarter of Fiscal Year 2018 Results

    NORTHVALE, N.J. , Aug. 21, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results ...

  • PR Newswire10 months ago

    ADM Tronics Expands Capabilities and Market Presence Through Strategic Relationship with Solution To Products Ltd.

    NORTHVALE, N.J., Aug. 9, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (ADMT), has entered into a multi-faceted Memorandum of Understanding (the "Memorandum") with Solution To Products, Ltd. ("S2P"). S2P, based in Israel and China, specializes in the development and production of high performance plastic, aluminum, metal and silicon parts for medical equipment as well as for general electronics, telecommunications, electro-optics and consumer products.  Under the Memorandum, ADMT will be able to utilize the efficiencies and expertise of S2P in ADMT's product development and production activities for its own proprietary medical device products as well as for customers. This relationship expands ADMT's engineering, development and production capabilities as well as providing S2P with the ability to offer its customers ADMT's regulatory expertise as well as a facility in a US location for engineering and production resources.

  • PR Newswire11 months ago

    ADM Tronics New Tinnitus Technologies Featured in Top Story in OneMedMarket "Sentinel Newsletter"

    NORTHVALE, N.J. , Aug. 3, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) is in development of two technologies for the tinnitus field.  These new developments were featured in the most ...

  • PR Newswire11 months ago

    ADM Tronics' Strong 2017 Fiscal Year Results Initiates Planned New Growth Strategy

    NORTHVALE, N.J., July 13, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (ADMT), recently reported Fiscal Year 2017 results, marking its third consecutive year of increased revenues and profits. The Fiscal Year-End 2017 results include a strengthened balance sheet with a strong cash position and the elimination of all bank debt. This financial progress enables the Company to initiate its planned redefinition of its business growth strategy, concentrating the scope of its activities as a medical technology innovator, specializing in the design, development and production of its own suite of proprietary therapeutic and diagnostic cutting-edge medical devices and related technologies, which are forthcoming in various stages of development. The first technology to be introduced is the "Tinnitus Shield™", an innovative, patent-pending hearing protection device specifically for the unique needs of the tinnitus marketplace. Tinnitus is a hearing condition commonly known as "ringing in the ears." The American Tinnitus Association estimates there are up to 50 million tinnitus sufferers in the U.S. and some 250 million worldwide. Tinnitus Shield™ will be marketed by ADMT's majority-owned subsidiary, Aurex International, Inc. and is projected to be on the market within the next two months, adding additional revenues to the Company's current strong financials.